The Centers for Medicare and Medicaid Services recently announced that they will no longer reimburse hospitals for costs of care associated with preventable in-hospital complications, including some common nosocomial infections such as catheter-associated urinary tract infections. This commentary discusses the clinical and economic consequences of this policy change for hospitals. While acknowledging that implementation of the rule poses challenges, the authors conclude that the new policy will benefit patients by encouraging hospitals to reduce preventable infections.